Asset
Anpocogin
Artiva Biotherapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05678205 | phase1_2 | withdrawn | 2023-08-01 | 2027-04-01 | Artiva Biotherapeutics, Inc. | A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors |
FDA applications (0)
This company has no applications containing this asset.